Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rangering i aksjer #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Aksjekurs
$0.16328419
Markedsverdi
$204.14K
Endring (1 dag)
4.35%
Endring (1 år)
102.45%
Land
GB
Handel Fusion Antibodies plc (FAB)

Kategori

EPS for Fusion Antibodies plc (FAB)
EPS per September 2025 TTM: $-0.02
Ifølge de siste økonomiske rapportene og aksjekursen til Fusion Antibodies plc er selskapets nåværende EPS (TTM) $-0.02. Ved slutten av 2024 hadde selskapet en EPS på $-0.05, en nedgang sammenlignet med EPS-en i 2023 som var $-0.12.
EPS-historikk for Fusion Antibodies plc fra 2013 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-0.02 -3.00%
2025 $-0.02 -54.35%
2024 $-0.05 -58.93%
2023 $-0.12 102.30%
2022 $-0.06 -59.83%
2021 $-0.15 286.73%
2020 $-0.04 -47.38%
2019 $-0.07 22.53%
2018 $-0.06 -994.12%
2017 $0.01 -90.93%
2016 $0.08 -1,393.10%
2015 $-0.01 -31.76%
2014 $-0.01 -73.60%
2013 $-0.03 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$3.62 -18,771.65%
DK
$15.47 -79,842.27%
US
$43.12 -222,368.04%
US
$9.62 -49,691.75%
BE
$38.32 -197,625.77%
NL